Interferon-alfa, interferon-lambda and hepatitis C. (Q50561807)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 September 2009

Language	Label	Description	Also known as
English	Interferon-alfa, interferon-lambda and hepatitis C.	scientific article published on 13 September 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

Interferon-alfa, interferon-lambda and hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

author name string

Thomas R O'Brien

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

language of work or name

0 references

publication date

13 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

Nature Genetics

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

41

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

10

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

1048-1050

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

1 reference

https://api.crossref.org/works/10.1038%2FNG.453

21 January 2018

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hepatitis C virus infection: genotyping and its clinical role

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beyond odds ratios — communicating disease risk based on genetic profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NIH Consensus Statement on Management of Hepatitis C: 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global epidemiology of hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19749756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FNG.453

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1038%2FNG.453

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/19749756

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50561807&oldid=2210364456"